Gruber A, Briese B, Areström I, Vitols S, Björkholm M, Peterson C
Division of Medicine, Karolinska Hospital, Stockholm, Sweden.
Leuk Res. 1993 Apr;17(4):353-8. doi: 10.1016/0145-2126(93)90023-e.
The purpose of the present study was to evaluate the distribution of the multiple drug resistance phenotype in leukemic cells with different levels of mdr1 gene expression. Peripheral leukemic cells from 8 patients (5 with detectable and 3 with undetectable mdr1 RNA levels) were incubated with daunorubicin (1 microM) in the absence and presence of verapamil (6.6 microM). Daunorubicin accumulation in individual cells was analysed by flow cytometry. Verapamil increased (16-45%) the mean daunorubicin accumulation in 7 of the 8 cell samples. In cells from 4 of these 7 patients, the fluorescence histograms showed a general increase of daunorubicin accumulation. The increase was limited to a small subpopulation of cells in one patient. In the remaining two patients an increase of daunorubicin accumulation was seen in the majority of cells, while cells with the highest accumulation were unaffected. In conclusion, verapamil can increase daunorubicin accumulation in leukemic cells with and without detectable mdr1 gene expression and the increase seems to affect the majority of the cell population.
本研究的目的是评估不同水平mdr1基因表达的白血病细胞中多重耐药表型的分布情况。来自8名患者的外周白血病细胞(5名患者的mdr1 RNA水平可检测到,3名患者的mdr1 RNA水平检测不到)在不存在和存在维拉帕米(6.6微摩尔)的情况下与柔红霉素(1微摩尔)一起孵育。通过流式细胞术分析单个细胞中柔红霉素的蓄积情况。维拉帕米使8个细胞样本中的7个样本的柔红霉素平均蓄积量增加(16% - 45%)。在这7名患者中的4名患者的细胞中,荧光直方图显示柔红霉素蓄积普遍增加。在一名患者中,这种增加仅限于一小部分细胞。在其余两名患者中,大多数细胞中可见柔红霉素蓄积增加,而蓄积量最高的细胞未受影响。总之,维拉帕米可增加mdr1基因表达可检测到和检测不到的白血病细胞中柔红霉素的蓄积,且这种增加似乎影响大多数细胞群体。